Keeping Current
Emerging Treatment Pathways for HFrEF Patients: What Does the Evidence Say?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:33:58
- Mas informaciones
Informações:
Sinopsis
Drs Anker, Hernandez, and Vaduganathan discuss the potential role of cardiac myosin activators in the treatment of patients with HFrEF. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939935?src=mkm_podcast_addon_939935